About Tellgen Corporation Company

The company was founded in 2003 and specializes in R&D, production, promotion and sales of high-end in vitro diagnostic products, and is committed to promoting the application of novel testing technology in the field of clinical testing. The company is mainly engaged in R&D, production and sales of self-branded in vitro diagnostic products. Currently, the products mainly involve a series of products with the main application directions of full tumor testing, autoimmunity, cardiovascular disease, pathogen infections, and reproductive health. According to the testing principle, the company's products can be divided into three categories: immune, molecular, and biochemical diagnostic products. The company comprehensively uses various technical platforms such as high-throughput fluorescence technology, chemiluminescence immunoassay technology, and multi-color fluorescence PCR technology to develop in vitro diagnostic reagents, forming a rich product line “mainly for clinical testing of the entire course of cancer, supplemented by testing products in other fields”, covering all aspects of the entire cancer course of “screening for disease - assisted diagnosis - personalized medication - prognosis and efficacy monitoring”, and is widely used in the field of clinical diagnosis.